Evaluation the effect of fenugreek on reducing blood lipids
- Conditions
- Hypercholesterolemia.
- Registration Number
- IRCT20210125050142N1
- Lead Sponsor
- ational institute for medical research development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Patients with low to moderate risk for cardiovascular events
LDL 116 -180 mg /d
Drinking alcohol,
Use of effective supplements on blood lipids (such as fish oil), Immunosuppressive drugs, blood lipid-lowering drugs (statins, fibrates, niacin, …)
People with hypothyroidism, nephrotic syndrome or renal dysfunction or liver dysfunction
People with uncontrolled hypertension (systolic blood pressure greater than 160 or diastolic blood pressure greater than 100 mmHg),
History of dizziness and convulsions,
Pregnancy or lactation
Sensitivity to studied plant
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean of Total Cholesterol. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of High-Density Lipoprotein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of Low-Density Lipoprotein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of Triglyceride. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of high-sensitivity C-reactive protein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.
- Secondary Outcome Measures
Name Time Method Mean of fasting blood sugar. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of blood pressure. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood pressure monitor.;Mean of body mass index. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Tape meters, digital scales and calculation formulas.